- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Projecting Pharma's Outlook with Deloitte's Laks Pernenkil
Published on:
Laks Pernenkil, a partner for Deloitte’s life sciences consulting business, discusses various findings from Deloitte’s research into the biopharma industry.
Laks Pernenkil, a partner for Deloitte’s life sciences consulting business, discusses various findings from Deloitte’s research into the biopharma industry with Grant Playter, associate editor. Topics of discussion include Deloitte’s recent report on the state of biopharma, broader digitalization trends, how generative AI will affect pharma going forward, the push toward supply chain resilience, and more.
About the speaker
[insert text]